Search Results 1401-1410 of 13319 for monoclonal antibody

1. SX-682 Treatment In Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab - Mayo Clinic

   History of severe hypersensitivity reaction to any monoclonal antibody. Women of Childbearing Potential (WOCBP) who are pregnant or breastfeeding. Women ...

2. DALY II USA/ MB-CART2019.1 For DLBCL - Mayo Clinic

   Prior lines of systemic therapy should include an anti-CD20 monoclonal antibody ... Prior BITE antibodies for cancer therapy. Prior T cell receptor ...

3. A Study of the Safety and Effectiveness of QPI-1002 for the Prevention of Delayed Graft Function in Transplant Recipients from Older Kidney Donors who have Died - Mayo Clinic

   ... monoclonal antibodies per center standard of care. Must be up-to-date on cancer screening according to site-specific guidelines and past medical history ...

4. A Phase 2/3 Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab in Subjects With Unresectable or Metastatic Melanoma - Mayo Clinic

   Has received prior adjuvant therapy, monoclonal antibody or an investigational agent or device within 4 weeks or 5 half-lives (whichever is longer); Has ...

5. Clinical trials - Oncology (Medical)

   The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

6. Low-Dose Selinexor and Choline Salicylate for the Treatment of Patients With Non-Hodgkin Lymphoma or Histiocytic/Dendritic Cell Neoplasms - Mayo Clinic

   an anti-CD38 monoclonal antibody - Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2 - Absolute neutrophil count (ANC) ...

7. TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study - Mayo Clinic

   Treatment with any monoclonal antibody within 3 months prior to Screening. Identified pre-existing ophthalmic disease that, in the judgment of the ...

8. Medical Research & Education - Mayo Clinic News Network

   Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...

9. Study Of Imprime PGG And Pembrolizumab In Advanced Melanoma And Triple Negative Breast Cancer - Mayo Clinic

   Had a prior anti-cancer monoclonal antibody (except immune CPI in the case of melanoma subjects) within 30 days prior to start of study treatment, or ...

10. Medical Research & Education - Mayo Clinic News Network

    Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...